Concepedia

Chang Rim Na

CR

Statistics

Publications

1

Citations

14

H-Index

1

Active since

2014

Chang Rim Na is an author specializing in monoclonal antibodies, rituximab-based therapy, and life sciences.

Publications per year

2014–2014

1

Publications

1

Successful rituximab B lymphocyte depletion therapy for angioedema due to acquired C1 inhibitor protein deficiency: association with reduced C1 inhibitor protein autoantibody titers.

David H. Dreyfus, Chang Rim Na, Christopher Randolph et al. · PubMed · 2014 · 14 citations

, , +8

1–1 of 1